Surgical Options for Neoplasia Complicating Crohn’s Disease of the Large Intestine
暂无分享,去创建一个
[1] M. Regueiro,et al. ACG Clinical Guideline: Management of Crohn’s Disease in Adults , 2018, The American Journal of Gastroenterology.
[2] A. Lightner. Segmental Resection versus Total Proctocolectomy for Crohn's Colitis: What is the Best Operation in the Setting of Medically Refractory Disease or Dysplasia? , 2018, Inflammatory bowel diseases.
[3] J. Toh. Surgery for Colorectal Cancer in Crohn's Disease: Should We Perform a Total Proctocolectomy for All Patients With High-Grade Dysplasia and Cancer in Crohn's Disease? , 2017, Diseases of the colon and rectum.
[4] E. Montgomery,et al. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease , 2017, Digestive Diseases and Sciences.
[5] E. Finlayson,et al. Changing Paradigms in Detection of Dysplasia and Management of Patients With Inflammatory Bowel Disease: Is Colectomy Still Necessary? , 2017, Gastroenterology.
[6] Zachary J. Heins,et al. Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease. , 2016, Gastroenterology.
[7] M. Pittman,et al. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. , 2016, Gastroenterology.
[8] D. Rubin,et al. Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia , 2016, Inflammatory bowel diseases.
[9] S. Steele,et al. Guideline for the Surgical Management of Crohn ’ s Disease , 2015 .
[10] Alan Barkun,et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. , 2015, Gastrointestinal endoscopy.
[11] John A. Evans,et al. The role of endoscopy in inflammatory bowel disease. , 2004, Gastrointestinal endoscopy.
[12] H. Sørensen,et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[13] S. Nordling,et al. Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: A case–control observational study based on registry data , 2014, International journal of cancer.
[14] A. Amiot,et al. European evidence based consensus for endoscopy in inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.
[15] N. Harpaz,et al. High Rates of Metachronous Colon Cancer or Dysplasia After Segmental Resection or Subtotal Colectomy in Crohn's Colitis , 2013, Inflammatory bowel diseases.
[16] B. V. Pedersen,et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. , 2012, Gastroenterology.
[17] J. Goldblum,et al. Dysplasia Associated With Crohn's Colitis: Segmental Colectomy or More Extended Resection? , 2012, Annals of surgery.
[18] Z. Cohen,et al. Long-term Outcome of Colectomy and Ileorectal Anastomosis for Crohn's Colitis , 2011, Diseases of the colon and rectum.
[19] H. Sokol,et al. Risk Factors for Neoplasia in Inflammatory Bowel Disease Patients With Pancolitis , 2010, The American Journal of Gastroenterology.
[20] P. M. O'Connor,et al. Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease , 2010, Inflammatory bowel diseases.
[21] J. Church,et al. Colorectal Cancer Complicating Inflammatory Bowel Disease: Similarities and Differences Between Crohn's and Ulcerative Colitis Based on Three Decades of Experience , 2010, Annals of Surgery.
[22] R. Steele,et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002) , 2010, Gut.
[23] R. McLeod,et al. Position Statement on the Diagnosis and Management of olorectal Neoplasia in Inflammatory Bowel Disease , 2022 .
[24] Lisa M. Schwartz,et al. When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations , 2008, Inflammatory bowel diseases.
[25] N. Harpaz,et al. Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[26] A. Zinsmeister,et al. Incidence and Prognosis of Colorectal Dysplasia in Inflammatory Bowel Disease: A Population‐based Study from Olmsted County, Minnesota , 2006, Inflammatory bowel diseases.
[27] A. Mellgren,et al. Crohn’s Colitis: The Incidence of Dysplasia and Adenocarcinoma in Surgical Patients , 2006, Diseases of the colon and rectum.
[28] K R Abrams,et al. Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease , 2006, Alimentary pharmacology & therapeutics.
[29] Noam Harpaz,et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. , 2003, Gastroenterology.
[30] P. Heidenreich,et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. , 2002, Gastrointestinal endoscopy.
[31] K. Abrams,et al. The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.
[32] R. Allan,et al. Smoking is a predictive factor for outcome after colectomy and ileorectal anastomosis in patients with Crohn's colitis , 1999, The British journal of surgery.
[33] C. Bernstein,et al. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? , 1994, The Lancet.
[34] A. Zinsmeister,et al. Dysplasia in chronic ulcerative colitis: Implications for colonoscopic surveillance , 1992, Diseases of the colon and rectum.
[35] H. Adami,et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement , 1990, The Lancet.